Table III.

HRT dosages and regimens associated with recurrent endometriosis in case reports and series.

HRT type	Dosages and regimens associated with recurrent postmenopausal endometriosis (n = 17 patients)
Oestrogen-only	1. Premarin 1.25 mg/day (Skor et al., 1977)
	2. Premarin (Kapadia et al., 1984)
	3. Oestrogens 2.5 mg/day (Ray et al., 1985)
	4. 2.5 mg oestrogen/day, but taking twice the recommended dose (Stewart and Ireland, 1977)
	5. Oestrogen patch 0.05 mg twice a week (Badawy et al., 2004)
	6. Conjugated oestrogen 1.25 mg/day (Giarenis et al., 2009)
	7. Oestradiol implant 100 mg 6 monthly for 5 years, subsequent 2 years of taking no hormones, then 2 weeks before admission felt run down and took three 10 μg tablets of ethinyloestradiol on consecutive days (Manyonda et al., 1989)
	8. 100 mg oestradiol annual hormone implants (Manyonda et al., 1989)
	9. Oestradiol implant (Taylor et al., 1999)
	10. Oestradiol implant (Taylor et al., 1999)
	11. Oestradiol implant (Taylor et al., 1999)
	12. First oestradiol implant, then Evorel 50 patches (Taylor et al., 2005)
Combined	13. Conjugated equine oestrogens 625 mcg, norethisterone 150 mcg cyclically (Mattar et al., 2008)
	14. Premarin 0.625 mg daily and Provera 10 mg daily for 12 days a month (Goh and Hall, 1992)
	15. Oestrogen + progesterone (Joseph et al., 1994)
	16. Oestrogen patch 0.05 mg weekly followed by various regimens of oestrogen and progestogen (Badawy et al., 2004)
	17. Oestradiol and cyproterone (Chahine et al., 2007)